Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Dapagliflozin Improves Glycemic Control and Reduces Body Weight as Add-on Therapy to Metformin Plus Sulfonylurea: A 24-Week Randomized, Double-Blind Clinical Trial
PaperCitations, authors & open-access status
Dapagliflozin Improves Glycemic Control and Reduces Body Weight as Add-on Therapy to Metformin Plus Sulfonylurea: A 24-Week Randomized, Double-Blind Clinical Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 150 citations, 2015 year and closed oa status.
150
Citations
2015
Year
closed
OA Status